Retinoblastoma: AJCC Staging Predicts Both Mortality and Globe Salvage

Feb. 17, 2021: AJCC-UICC retinoblastoma staging brings ophthalmic oncology care into the mainstream of world medical oncology and research. Accepted by all other specialties for other cancers, it allows for seamless communication, comparative studies and outcomes research. Herein, Dr. Ankit Tomar represents the AJCC Ophthalmic Oncology Task Force's multicenter, international effort that compared AJCC RB staging to CHLA, WEH and others. Watch this video to better understand how much more functional AJCC retinoblastoma staging can be and how it will improve patients care.

The Eye Cancer Foundation

Established in 1998, The Eye Cancer Foundation is an educational and supportive resource for eye cancer patients, their families, and physicians.

Learn more »

Support our mission

Help make a difference in the lives of everyone affected by eye cancer. The Eye Cancer Foundation depends on the generosity of individuals, businesses, churches, foundations and organizations.

Donate Now »

Donate Later »

MAILING ADDRESS

115 East 61st Street, Suite 5B New York, NY 10065
(212) 832-8170 [email protected]